Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Uppsala Biotech AB
AB
Active
Org 5569389405
Vårdkasvägen 7, 756 55
Uppsala
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2013 · 12 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Engineering activities and related technical consultancy
/
Uppsala Biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
EBITDA
SEK millions
2M
2M
1M
1M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 2M (+100% vs 2022)
2M
+100%
2023
2024: 1M (-50% vs 2023)
1M
-50%
2024
2025: 0M (-100% vs 2024)
0M
-100%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
1 182
1 055
2 381
2 162
1 969
Staff expenses
−788
−48
−263
—
—
EBITDA
146
737
1 865
959
1 088
Depreciation & amort.
−9
−9
−9
−12
−7
EBIT
119
729
1 857
947
1 081
Net financials
−117
128
−1 616
11
3
Profit before tax
4
857
340
1 110
1 182
Tax
−22
−173
−352
−230
−245
Net profit
−18
684
−12
880
937
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
4 326
6 691
6 324
6 654
6 367
Equity
4 173
4 400
3 921
4 241
3 635
Long-term debt
0
2 290
2 307
2 313
2 314
Short-term debt
153
0
95
0
166
Total debt
153
2 290
2 403
2 313
2 480
Financial ratios
5-year trend
EBITDA margin
12,4 %
This company
15,8 %
Market median
This company
Market median
22% below market
2021
2025
Equity ratio
96,5 %
This company
38,2 %
Market median
This company
Market median
153% above market
2021
2025
Return on equity
−0,4 %
This company
18,4 %
Market median
This company
Market median
102% below market
2021
2025
Net profit margin
−1,5 %
This company
8,1 %
Market median
This company
Market median
119% below market
2021
2025
Asset turnover
0,27×
This company
1,12×
Market median
This company
Market median
76% below market
2021
2025
Debt / equity
0,04×
This company
0,62×
Market median
This company
Market median
94% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Uppsala Biotech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
